DAX19.671 -3,0%ESt504.622 -3,2%Top 10 Crypto11,20 +7,7%Dow40.608 +7,9%Nas17.125 +12,2%Bitcoin75.130 -0,4%Euro1,0965 +0,1%Öl64,96 -1,2%Gold3.115 +1,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 Tesla A1CX3T Apple 865985 Amazon 906866 RENK RENK73 Allianz 840400 Infineon 623100 Mercedes-Benz Group (ex Daimler) 710000 Lufthansa 823212 BASF BASF11 Volkswagen (VW) vz. 766403 BYD A0M4W9 Microsoft 870747 Deutsche Bank 514000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Trump kündigt Zollpause an: US-Börsen mit Mega-Erholung -- Bitcoin deutlich stärker -- Deutsche Bank erhöht Goldpreisprognose -- Novo Nordisk, Tesla, Ölpreis, VW im Fokus
Top News
Trotz Marktturbulenzen: NVIDIA-Aktie mit über 100 Prozent Kurspotenzial laut BoA Trotz Marktturbulenzen: NVIDIA-Aktie mit über 100 Prozent Kurspotenzial laut BoA
Trump-Zölle schocken Märkte: Das erwarten Experten für Bitcoin & Co. Trump-Zölle schocken Märkte: Das erwarten Experten für Bitcoin & Co.
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Sage Therapeutics Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
6,26 EUR +0,45 EUR +7,71 %
STU
6,91 USD +0,52 USD +8,10 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.358,09 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA117WF

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS78667J1088

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolSAGE

Sage Therapeutics Aktien News

DatumMeistgelesen
BenzingaBiogen Terminates Collaboration With Sage Therapeutics For Neurological Disorder Candidate
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAGE
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAGE
PR NewswireSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit
PR NewswireSage Potash Shares to Resume Trading
PR NewswireSage Potash Shares to Resume Trading
PR NewswireCanadian Investment Regulatory Organization Trade Resumption - SAGE
PR NewswireCanadian Investment Regulatory Organization Trade Resumption - SAGE
PR NewswireSAGE SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAGE
PR NewswireCanadian Investment Regulatory Organization Trading Halt - SAGE
PR NewswireCanadian Investment Regulatory Organization Trading Halt - SAGE
PR NewswireSage Potash Announces Equipment Purchase and Financing
PR NewswireSage Potash Announces Equipment Purchase and Financing
PR NewswireSage Potash Announces Equipment Purchase and Financing
PR NewswireSage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAGE
PR NewswireSAGE SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
ZacksSage Therapeutics (SAGE) Down 17.1% Since Last Earnings Report: Can It Rebound?
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE
ZacksSage Therapeutics (SAGE) Q2 Loss Wider Than Expected, Sales Rise
ZacksSage Therapeutics, Inc. (SAGE) Reports Q2 Loss, Tops Revenue Estimates
BenzingaExpert Outlook: Sage Therapeutics Through The Eyes Of 14 Analysts
ZacksThe Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE
ZacksSage Therapeutics, Inc. (SAGE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
PR NewswireSAGE POTASH ANNOUNCES APPOINTMENTS OF A NEW BOARD OF DIRECTORS MEMBER, STRATEGIC OPERATIONS PARTNER AND GLOBAL FINANCE & TRADE PARTNER
PR NewswireSAGE POTASH ANNOUNCES APPOINTMENTS OF A NEW BOARD OF DIRECTORS MEMBER, STRATEGIC OPERATIONS PARTNER AND GLOBAL FINANCE & TRADE PARTNER
PR NewswireSAGE POTASH ANNOUNCES APPOINTMENTS OF A NEW BOARD OF DIRECTORS MEMBER, STRATEGIC OPERATIONS PARTNER AND GLOBAL FINANCE & TRADE PARTNER
Benzinga19 Analysts Have This To Say About Sage Therapeutics
BenzingaSage Therapeutics Reports Phase 2 Huntington's Data
PR NewswireSage Potash Grants Stock Options
PR NewswireSage Potash Grants Stock Options
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
BenzingaCracking The Code: Understanding Analyst Reviews For Sage Therapeutics
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
PR NewswireSage Potash Announces Non-Brokered Private Placement of 13,500,000 shares
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
Wer­bung

Sage Therapeutics News

Sage Therapeutics News: auf dieser Seite finden Sie alle Sage Therapeutics News und Nachrichten zur Sage Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Sage Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Sage Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.